For a detailed breakdown, see our guide on what to expect after your first tirzepatide dose
Anant Vinjamoori, the chief medical officer of Hims, told the committee that allowing his company and others to sell the drug is the safer choice
Gourdy P, Guillaume M, Fontaine C, et al
Be open about any digestive symptoms you experience, as your healthcare provider can adjust your treatment plan, provide additional support, or investigate alternative causes if needed
The test ($99 add-on) identifies your GLP1R, GIPR, FTO, and MC4R variantsgenetic predictors of how strongly you'll respond to semaglutide and whether you'll benefit from higher doses or dual-compound therapy
GLP-1 appetite-suppressing drugs are showing up in UK grocery data, with estimates suggesting roughly 5% of adults use them and retailers adjusting to changing baskets